← vista completa

Publicado el 1 de agosto de 2009 | http://doi.org/10.5867/medwave.2009.08.4074

Cáncer ovárico epitelial: relación entre el factor de crecimiento nervioso (NGF) y la angiogénesis

Epithelial ovarian cancer: relationship between nerve growth factor (NGF) and angiogenesis

Paulina Ormazábal Leiva

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Paulina Ormazábal Leiva

Laboratorio de Endocrinología y Biología de la Reproducción, Hospital Clínico Universidad de Chile, Santiago, Chile

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Ormazábal Leiva P. Epithelial ovarian cancer: relationship between nerve growth factor (NGF) and angiogenesis. Medwave 2009;9(08):e4074 doi: 10.5867/medwave.2009.08.4074

Publicación 01/08/2009

Métricas del artículo

Artículo no tiene métricas.

Notas

Referencias

  1. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 2001 Apr;22(2):255-88. | CrossRef | PubMed
  2. Dyck HG, Hamilton TC, Godwin AK, Lynch HT, Maines-Bandiera S, Auersperg N. Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer. Int J Cancer. 1996 Dec 20;69(6):429-36. | CrossRef | PubMed
  3. Fleming JS, Beaugié CR, Haviv I, Chenevix-Trench G, Tan OL. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol. 2006 Mar 9;247(1-2):4-21. Epub 2005 Nov 16. | CrossRef | PubMed
  4. Murdoch WJ, McDonnel AC. Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction. 2002 Jun;123(6):743-50. | CrossRef | PubMed
  5. Parrott JA, Nilsson E, Mosher R, Magrane G, Albertson D, Pinkel D, et al. Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells. Mol Cell Endocrinol. 2001 Apr 25;175(1-2):29-39. | CrossRef | PubMed
  6. Jordan S, Green A, Webb P. Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk? Cancer Causes Control. 2006 Jun;17(5):623-32. | CrossRef | PubMed
  7. Scully RE. Classification of human ovarian tumors. Environ Health Perspect. 1987 Aug;73:15-25. | CrossRef | PubMed
  8. Ødegaard E, Staff AC, Abeler VM, Kopolovic J, Onsrud M, Lazarovici P, et al. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma. Hum Pathol. 2007 Jan;38(1):140-6. Epub 2006 Sep 25. | PubMed
  9. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609-42. Epub 2003 Mar 27. | PubMed
  10. Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, et al. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin Cancer Res. 2003 Jun;9(6):2248-59. | PubMed
  11. Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett. 2001 Aug 28;169(2):107-14. | CrossRef | PubMed
  12. Mak HH, Peschard P, Lin T, Naujokas MA, Zuo D, Park M. Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway. Oncogene. 2007 Nov 8;26(51):7213-21. Epub 2007 May 28. | CrossRef | PubMed
  13. Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, Vetuschi A, et al. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell. 2004 Oct;6(4):347-60. | CrossRef | PubMed
  14. Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M. Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol. 1989 Jan;9(1):24-33. | PubMed
  15. Mitra G, Martin-Zanca D, Barbacid M. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6707-11. | CrossRef | PubMed
  16. Pierotti MA, Greco A. Oncogenic rearrangements of the NTRK1/NGF receptor. Cancer Lett. 2006 Jan 28;232(1):90-8. Epub 2005 Oct 20. | CrossRef | PubMed
  17. Tacconelli A, Farina AR, Cappabianca L, Gulino A, Mackay AR. TrkAIII. A novel hypoxia-regulated alternative TrkA splice variant of potential physiological and pathological importance. Cell Cycle. 2005 Jan;4(1):8-9. Epub 2005 Jan 5. | CrossRef | PubMed
  18. Vicente Rodrigo Guanter. Estudio del factor de crecimiento del endotelio vascular (VEGF) y del factor de crecimiento fibroblástico básico (BFGA) en la patología benigna y maligna de la próstata. Tesis doctoral. Universitat de Valencia, Facultat de Medicina i Odontología, Departament de Cirurgia. Servei de publicacions: 39-64, 2005. | Link
  19. Martínez J. Angiogénesis tumoral. XLVII Reunión Nacional de la AEHH y XXI Congreso Nacional de la SETH, Lección conmemorativa. Haematologica/edición española .90 (Supl 1): 85- 94. 2005. | Link
  20. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997 Feb;18(1):4-25. | CrossRef | PubMed
  21. Campos X, Muñoz Y, Selman A, Yazigi R, Moyano L, Weinstein-Oppenheimer C, et al. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. Gynecol Oncol. 2007 Jan;104(1):168-75. Epub 2006 Aug 28. | CrossRef | PubMed
  22. Abulafia O, Sherer DM. Angiogenesis of the ovary. Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):240-6. | CrossRef | PubMed
  23. Julio-Pieper M, Lara HE, Bravo JA, Romero C. Effects of nerve growth factor (NGF) on blood vessels area and expression of the angiogenic factors VEGF and TGFbeta1 in the rat ovary. Reprod Biol Endocrinol. 2006 Nov 10;4:57. | CrossRef | PubMed
  24. Cantarella G, Lempereur L, Presta M, Ribatti D, Lombardo G, Lazarovici P, et al. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J. 2002 Aug;16(10):1307-9. Epub 2002 Jun 21. | PubMed